LUMILAM ARTEMETHER 80mg. IP + LUMEFANTRINE 480mg. IP

Lumilam tablets (Artemether 80 mg + Lumefantrine 480 mg) are used for the treatment of acute, uncomplicated malaria from Plasmodium falciparum. Main uses: treatment of acute, uncomplicated malaria caused by Plasmodium falciparum; meant for infections in areas where resistance to chloroquine has been reported; to be used only at the age, weight and dose for which a doctor has prescribed this 80 mg/480 mg strength.

Common side effects of Lumilam Tablet include headache; loss of appetite; dizziness; weakness and tiredness; joint pain; muscle pain. Get medical help at once if you notice prolongation of the QT interval on the electrocardiogram (ECG); serious allergic or hypersensitivity reactions, including rash and swelling.

Each Lumilam tablet contains Artemether 80 mg + Lumefantrine 480 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Lumilam Tablet only as your doctor advises.

The MRP of Lumilam Tablet is ₹139.69 for a pack of 10x6 (Blister). For chemists and distributors, the PTR is ₹106.43 and the PTS is ₹95.79.

Each Lumilam tablet contains Artemether 80 mg + Lumefantrine 480 mg. It comes in a pack of 10x6 (Blister).

The two ingredients work in turn against the malaria parasite. Artemether brings down the number of parasites in the blood, while lumefantrine clears the parasites that remain over a longer period and helps stop the infection from returning again. Both are antimalarial medicines.

Must not be used if you are allergic to artemether, lumefantrine or any ingredient of the tablet. Must not be used for severe or complicated Plasmodium falciparum malaria. Must not be used to prevent malaria. Must not be used with strong CYP3A4 inducers such as rifampin, carbamazepine, phenytoin or St. John's wort; halofantrine and these tablets should not be administered within one month of each other. Must not be used in patients with known QT prolongation (including congenital long QT syndrome), low potassium (hypokalemia) or low magnesium (hypomagnesemia) levels, or in those taking other medicines that prolong the QT interval.

Lumilam Tablet is a brand of Vibcare Pharma, sold through its Evermed division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.